← All trials
NCT03892161
Phase 1Interventional
Includes initial studies to determine the metabolism and pharmacologic actions of drugs in humans, the side effects associated with increasing doses, and to gain early evidence of effectiveness; may include healthy participants and/or patients.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Apr 12, 2018
- Primary completion
- Nov 22, 2018
- Completion date
- Nov 22, 2018
- First posted
- —
- Last posted
- —
- Enrollment
- 17
- Arms / groups
- 5 / —
- Source
- AACT · ingestion pipeline
Sponsors
- University of Cape TownLead sponsor
- Wits UniversityCollaborator
- University of Cape TownOverall official - principal investigator
- University of Cape TownReponsible party - principal investigator
- Desmond Tutu HIV CentreCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.